Skip to main navigation Skip to search Skip to main content

Mutations in gyrA and gyrB in moxifloxacin-resistant mycobacterium avium complex and mycobacterium abscessus complex clinical isolates

  • Su Young Kim
  • , Byung Woo Jhun
  • , Seong Mi Moon
  • , Sun Hye Shin
  • , Kyeongman Jeon
  • , O. Jung Kwon
  • , In Young Yoo
  • , Hee Jae Huh
  • , Chang Seok Ki
  • , Nam Yong Lee
  • , Sung Jae Shin
  • , Charles L. Daley
  • , Gee Young Suh
  • , Won Jung Koh
  • Sungkyunkwan University
  • Yonsei University
  • National Jewish Health

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Abstract

Data on the frequency of gyrA and gyrB mutations in fluoroquinolone-resistant isolates of the Mycobacterium avium complex (MAC) and the Mycobacterium abscessus complex (MABC) are limited. In our analysis, we did not find any resistance-associated mutations in gyrA or gyrB in 105 MAC or MABC clinical isolates, including 72 moxifloxacin-resistant isolates. Our findings suggest that mechanisms other than gyrA and gyrB mutations contribute to moxifloxacin resistance in these organisms.

Original languageEnglish
Article numbere00527-18
JournalAntimicrobial Agents and Chemotherapy
Volume62
Issue number9
DOIs
StatePublished - Sep 2018

Bibliographical note

Publisher Copyright:
Copyright © 2018 American Society for Microbiology. All Rights Reserved.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Gyrase mutation
  • Moxifloxacin
  • Mycobacterium abscessus complex
  • Mycobacterium avium complex
  • Resistance

Fingerprint

Dive into the research topics of 'Mutations in gyrA and gyrB in moxifloxacin-resistant mycobacterium avium complex and mycobacterium abscessus complex clinical isolates'. Together they form a unique fingerprint.

Cite this